SCHEMBL7112746

SCHEMBL7112746

O=C1Cc2cc(F)ccc2Oc2cc(O)c(O)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.36
LDHA P00338 1/20 0.35
LDHB P07195 1/20 0.35
STK17B O94768 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
FABP6 P51161 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
EPHX2 P34913 1/20 0.33
ACHE P22303 1/20 0.33
MAOB P27338 6/20 0.32
ALOX12 P18054 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
PKM P14618 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7115791 0.88 ACHE (0.36) LDHALDHBSTK17BACHEMAOB
SCHEMBL7116800 0.86 ACHE (0.39) STK17BKDM4EALDH1A1GAAACHE
SCHEMBL7112749 0.82 AR (0.41) NOTUMLDHALDHBL3MBTL1MAOB
SCHEMBL7110714 0.82 ALOX15 (0.39) LDHALDHBKDM4EALDH1A1MAOB
SCHEMBL7112833 0.80 MAOA (0.50) NOTUMLDHALDHBSTK17BKDM4E
SCHEMBL7112415 0.79 TDP2 (0.40) MAOB
SCHEMBL7116108 0.79 ALDH1A1 (0.40) LDHALDHBALDH1A1GAAL3MBTL1
SCHEMBL7110960 0.79 KDM4E (0.39) KDM4EALDH1A1GAAACHEMAOB
SCHEMBL11575864 0.79 MAOB (0.42) STK17BKDM4EALDH1A1GAAEPHX2
SCHEMBL7114542 0.78 MEN1 (0.45) ALDH1A1GAAL3MBTL1MAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065021-A1 Tracheal smooth muscle relaxants YAMASHITA SHINYA (JP) 2003-04-03 US disclosed
US-6495592-B1 DIBENZ(B,F)OXEPIN DERIVATIVES; ANTIASTHMATICS NIPPON SUISAN KAISHA, LTD. (JP) 2002-12-17 US disclosed
EP-0805155-B1 NOVEL ANTIOXIDANT TRICYCLIC FUSED HETEROCYCLIC COMPOUND NIPPON SUISAN KAISHA LTD (JP) 2002-03-13 EP disclosed
US-6180659-B1 USING A DIBENZO(B,F)-(OXEPIN OR THIEPIN) COMPOUND NIPPON SUISAN KAISHA, LTD. (JP) 2001-01-30 US disclosed
EP-0885610-A1 TRACHEAL SMOOTH MUSCLE RELAXANT NIPPON SUISAN KAISHA, LTD. (JP) 1998-12-23 EP disclosed
EP-0805155-A1 NOVEL ANTIOXIDANT TRICYCLIC FUSED HETEROCYCLIC COMPOUND NIPPON SUISAN KAISHA, LTD. (JP) 1997-11-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065021-A1 Tracheal smooth muscle relaxants MYLK, MUSK, CPT1B NOTUM 837/4885LDHA 2411/4885LDHB 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.